Enter assignee name

Trademarks = 4

Forward Citations = 482

Loading Chart...

5 inventors (with patents filed for the assignee):

Edward M Rudnic (24 out of 48 patents)

Sandra E Wassink (23 out of 35 patents)

Donald J Treacy, Jr (23 out of 27 patents)

4. James D Isbister (22 out of 25 patents)

5. James D Isbiter (1 out of 1 patent)

24 patents: Sort by Forward Citations

1. 7157095 - Multiple-delayed release antifungal product, use and formulation thereof (2007-01-02),

2. 7122204 - Antibiotic composition with inhibitor (2006-10-17),

3. 7108859 - Antineoplastic product, use and formulation thereof (2006-09-19),

4. 7105174 - Multiple-delayed release anti-neoplastic product, use and formulation thereof (2006-09-12),

5. 7074417 - Multiple-delayed release anti-viral product, use and formulation thereof (2006-07-11),

6. 7025989 - Multiple-delayed released antibiotic product, use and formulation thereof (2006-04-11),

7. 6991807 - Antibiotic composition (2006-01-31),

8. 6984401 - Antiviral product, use and formulation thereof (2006-01-10),

9. 6929804 - Anti-fungal composition (2005-08-16),

10. 6730320 - Tetracycline antibiotic product, use and formulation thereof (2004-05-04),

11. 6723341 - Antibiotic product, use and formulation thereof (2004-04-20),

12. 6669948 - Antibiotic product, use and formulation thereof (2003-12-30),

13. 6667057 - Levofloxacin antibiotic product, use and formulation thereof (2003-12-23),

14. 6667042 - Fluroquinilone antibiotic product, use and formulation thereof (2003-12-23),

15. 6663891 - Erythromyacin antibiotic product, use and formulation thereof (2003-12-16),

Advancis Pharmaceutical Corporation is a leading pharmaceutical company that specializes in developing and commercializing novel anti-infective drugs. With a focus on providing innovative solutions for infectious diseases, Advancis aims to improve patient outcomes and address unmet medical needs. For over two decades, Advancis has been committed to researching and developing unique formulations using its proprietary controlled-release technology platform. This approach allows for optimized dosing and improved patient compliance. Through strategic partnerships and collaborations, Advancis continues to expand its product portfolio and global presence. Visit their website to learn more about their products, research initiatives, and contributions to the field of anti-infective drugs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

24 Patents

#11 in Germantown, MD

#171 in Maryland

#13,406 in US

#25,835 in the World

Germantown, MD, United States of America

Advancis Pharmaceutical Corporation